Skip to main content

Tracheostomy

0
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Atos Medical
Atos MedicalSweden - Horby
4 programs
TW speaking valve/HMEN/A1 trial
TrachPhone HMEN/A1 trial
TrachPhone Heat and Moisture ExchangerN/A
Tracheostomy Speaking Valve with Heat and Moisture ExchangerN/A
Active Trials
NCT01976819Completed16Est. Apr 2014
NCT06487104Enrolling By Invitation22Est. Apr 2026
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
TracheostomyN/A1 trial
Active Trials
NCT07404592CompletedEst. Oct 2025
Renovion
RenovionNC - Chapel Hill
1 program
ARINA-1PHASE_11 trial
Active Trials
NCT05658029Withdrawn0Est. Sep 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
RenovionARINA-1
City TherapeuticsTracheostomy
Atos MedicalTrachPhone HME
Atos MedicalTW speaking valve/HME

Clinical Trials (4)

Total enrollment: 38 patients across 4 trials

An Investigator-initiated Study to Evaluate Safety and Efficacy of ARINA-1 in People With a Tracheostomy

Start: May 2023Est. completion: Sep 20230
Phase 1Withdrawn

Tracheostomy Practices in Adult Intensive Care Units: A Multicentre Study in Izmir

Start: Sep 2025Est. completion: Oct 2025
N/ACompleted

Use of TrachPhone in Tracheostomized Patients

Start: Feb 2025Est. completion: Apr 202622 patients
N/AEnrolling By Invitation
NCT01976819Atos MedicalTW speaking valve/HME

Clinical Assessment of New Speaking Valve With Heat and Moisture Exchanger (HME) for Tracheotomized Patients

Start: Oct 2013Est. completion: Apr 201416 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.